Susquehanna Reaffirms “Hold” Rating for Mead Johnson Nutrition Co. (MJN)
Mead Johnson Nutrition Co. (NYSE:MJN)‘s stock had its “hold” rating reissued by research analysts at Susquehanna in a research note issued to investors on Wednesday. They presently have a $90.00 target price on the stock. Susquehanna’s target price points to a potential upside of 12.35% from the company’s previous close.
MJN has been the subject of several other reports. Credit Suisse Group AG set a $100.00 price target on shares of Mead Johnson Nutrition and gave the stock a “buy” rating in a report on Monday, September 12th. Goldman Sachs Group Inc. cut their price target on shares of Mead Johnson Nutrition from $96.00 to $85.00 and set a “neutral” rating for the company in a report on Tuesday, September 27th. Citigroup Inc. cut their price target on shares of Mead Johnson Nutrition from $106.00 to $103.00 and set a “buy” rating for the company in a report on Thursday, September 8th. BMO Capital Markets reissued an “outperform” rating and set a $97.00 price target on shares of Mead Johnson Nutrition in a report on Friday, September 23rd. Finally, Zacks Investment Research cut shares of Mead Johnson Nutrition from a “hold” rating to a “sell” rating in a report on Tuesday, October 4th. One analyst has rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $94.33.
Mead Johnson Nutrition (NYSE:MJN) opened at 80.11 on Wednesday. The stock has a market capitalization of $14.79 billion, a price-to-earnings ratio of 30.14 and a beta of 1.26. Mead Johnson Nutrition has a 1-year low of $65.53 and a 1-year high of $94.40. The firm has a 50-day moving average of $79.57 and a 200-day moving average of $84.54.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/19/susquehanna-reaffirms-hold-rating-for-mead-johnson-nutrition-co-mjn.html
Mead Johnson Nutrition (NYSE:MJN) last announced its earnings results on Thursday, July 28th. The company reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.10. The business earned $941.50 million during the quarter, compared to analysts’ expectations of $967.25 million. Mead Johnson Nutrition had a net margin of 13.28% and a negative return on equity of 194.30%. The business’s revenue was down 8.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.76 earnings per share. Equities research analysts anticipate that Mead Johnson Nutrition will post $3.48 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Monday, October 3rd. Stockholders of record on Monday, September 19th were given a $0.4125 dividend. This represents a $1.65 annualized dividend and a dividend yield of 2.06%. The ex-dividend date of this dividend was Thursday, September 15th. Mead Johnson Nutrition’s dividend payout ratio (DPR) is currently 62.03%.
In other news, SVP Graciela Monteagudo sold 45,873 shares of Mead Johnson Nutrition stock in a transaction that occurred on Friday, August 5th. The shares were sold at an average price of $87.64, for a total value of $4,020,309.72. Following the transaction, the senior vice president now directly owns 13,800 shares of the company’s stock, valued at $1,209,432. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Kimberly A. Casiano sold 710 shares of Mead Johnson Nutrition stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $89.75, for a total transaction of $63,722.50. Following the completion of the transaction, the director now directly owns 7,110 shares in the company, valued at $638,122.50. The disclosure for this sale can be found here. 0.50% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. FNY Managed Accounts LLC purchased a new position in Mead Johnson Nutrition during the third quarter valued at $125,000. MAI Capital Management increased its position in Mead Johnson Nutrition by 1.4% in the third quarter. MAI Capital Management now owns 35,402 shares of the company’s stock valued at $2,797,000 after buying an additional 505 shares during the period. BTIM Corp. increased its position in Mead Johnson Nutrition by 3.7% in the third quarter. BTIM Corp. now owns 25,608 shares of the company’s stock valued at $2,024,000 after buying an additional 923 shares during the period. National Pension Service increased its position in Mead Johnson Nutrition by 8.7% in the third quarter. National Pension Service now owns 153,267 shares of the company’s stock valued at $12,110,000 after buying an additional 12,227 shares during the period. Finally, MSI Financial Services Inc increased its position in Mead Johnson Nutrition by 13.7% in the third quarter. MSI Financial Services Inc now owns 2,632 shares of the company’s stock valued at $208,000 after buying an additional 318 shares during the period. 96.93% of the stock is currently owned by institutional investors and hedge funds.
Mead Johnson Nutrition Company Profile
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.
Receive News & Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related companies with MarketBeat.com's FREE daily email newsletter.